ArticleCureus2026
Acute Myeloid Leukemia Presenting As Spontaneous Splenic Rupture: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spontaneous splenic rupture (SSR) is a rare but potentially life-threatening condition that may occur in the setting of underlying splenic pathology, including hematologic malignancies such as acute myeloid leukemia (AML). We report the case of a 28-year-old man who presented with sudden-onset severe abdominal pain. Imaging revealed massive hemoperitoneum secondary to SSR. Laboratory investigations demonstrated severe anemia, thrombocytopenia, leukocytosis, and circulating blasts on peripheral smear, with normal coagulation parameters. The patient underwent urgent splenectomy, and histopathological examination showed extensive infiltration by myeloperoxidase-positive blasts. Bone marrow aspiration and immunophenotyping confirmed AML with a complex karyotype and adverse prognostic features. Despite initiation of induction chemotherapy, the clinical course was complicated by septic shock leading to death. This case highlights SSR as a rare initial manifestation of AML and emphasizes the importance of early recognition, prompt imaging, and multidisciplinary management to improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.